Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Tread Carefully Before Buying Falling Knife Ford Stock

In other words, watch out with falling knife F stock. Shares may have rebounded from under $4 per share to over $5 per share in a matter of days. But it may pay to wait-and-see, and enter at a more compelling entry point.

Look For Better Buys Than Coronavirus Play INO Stock

Biotech investing is tough. If you have a background in this space, sure, knock yourself out. But if you are an investor looking for solid opportunities, look elsewhere, and avoid INO stock. As the overall market recovers, there are plenty of other screaming buys to consider.

Despite Stimulus, Uncertainty Remains for Grounded American Airlines Stock

Until we know how much the coronavirus from China will set the moribund airline back, stay on the sidelines with AAL stock.

Uncertainty Remains, but AVGO Stock Is a Buy at These Levels

What's the call? Buy AVGO stock, at today's reasonable prices. Even if shares fall short of retracing their high water mark, investors could see material near-term upside.

Even If Markets Rebound, XOM Stock Could Tread Water

Bottom line? I don't see XOM stock falling further. But I also don't see it retracing its high water mark. Considering other blue-chip names that could quickly rebound, stay on the sidelines with this stock, and pursue more solid opportunities.

3 Cybersecurity Stocks Whose Work Is More Important Than Ever

Recent and existing headwinds could already be factored into cybersecurity stocks. However, keep these three on your radar as long-term buys.

Keep GOOG Stock on Your Radar as Markets Continue to Tumble

Bottom line: while other opportunities offer greater upside, they also offer heavier risk to boot. On the other hand, GOOG shares represent a wonderful business, selling for a fair price. Don't expect this stock to light the world on fire. But for what I like to call a "NASDAQ blue chip" opportunity, consider shares a buy, at today's prices and below.

Don’t Waste Time and Risk Capital on Coronavirus Play IBIO Stock

The recent market meltdown has wrecked havoc on portfolios. But it's also given investors the opportunity to buy high quality stocks selling at low valuations. Don't waste time and risk capital on IBIO stock and other coronavirus plays. Instead, pursue less-risky, but high-upside potential buys available in today's current enviornment.

Sell High-Risk Nio Stock After Its Results Confirm the Worst

In short, Nio stock could head lower, as the company remains on shaky ground. Since October, short interest has fallen from 28.8% of float to 22.5%, reducing chances of a short squeeze. As recent results confirm the worst, shares remain a sell even as they head below $2.50 per share.

Despite This Big Drop, Overvalued AMD Stock Has More Downside

Bottom line: sell AMD stock. Don't get FOMO and "buy the dip." With shares likely to tumble further, there's nothing you're missing out on.